Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceritinib plus capecitabine vs lapatinib plus capecitabine in HER2-positive advanced breast cancer
CTR20161036Phase 2Active
- Sponsor
- Qilu Pharmaceutical
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ceritinib in breast cancer, sponsored by Qilu Pharmaceutical. Started Jan 2017; status: active.
02
Drugs
ceritinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20161036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20161036.